REGENXBIO Inc.
RGNX
$12.77
$0.564.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.50% | 27.17% | 39.38% | 13.81% | 8.34% |
| Total Depreciation and Amortization | -4.59% | -6.46% | -7.69% | -6.38% | -3.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.95% | -17.61% | -29.91% | -16.62% | -7.05% |
| Change in Net Operating Assets | 714.33% | 1,259.92% | 184.84% | 150.82% | 123.28% |
| Cash from Operations | 43.32% | 54.02% | 56.44% | 20.73% | 16.02% |
| Capital Expenditure | -20.22% | 21.58% | 49.06% | 75.54% | 82.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -110.19% | -102.63% | -6.01% | -47.30% | -49.67% |
| Cash from Investing | -113.52% | -106.03% | -4.27% | -45.82% | -47.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.02% | -98.95% | -99.01% | 1,527.87% | 1,563.54% |
| Repurchase of Common Stock | 34.54% | 47.26% | 37.69% | -130.79% | -130.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 364.60% | 359.81% | 21.87% | 6.06% | -12.66% |
| Cash from Financing | 34.09% | 21.51% | -135.69% | 365.07% | 377.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.72% | 297.04% | -60.06% | 136.85% | 105.13% |